$MTRI News
Last published 9h ago
- 9h agoMTRITrading halt: Mentari Therapeutics, Inc. Cmn (MTRI), Volatility trading pauseNasdaq Trading HaltsHalted 2026-11-11 09:32:33.436 ET, resumption quote 2026-11-11 09:32:33 ET, resumption trade none.
- 2d agoMTRITrading halt: Mentari Therapeutics, Inc. Cmn (MTRI), Volatility trading pauseNasdaq Trading HaltsHalted 2026-11-09 14:34:22.533 ET, resumption quote 2026-11-09 14:34:22 ET, resumption trade none.
- 2d agoMTRITrading halt: Mentari Therapeutics, Inc. Cmn (MTRI), Volatility trading pauseNasdaq Trading HaltsHalted 2026-11-09 14:18:59.486 ET, resumption quote 2026-11-09 14:18:59 ET, resumption trade none.
- 2d agoMTRITrading halt: Mentari Therapeutics, Inc. Cmn (MTRI), Volatility trading pauseNasdaq Trading HaltsHalted 2026-11-09 13:18:50.226 ET, resumption quote 2026-11-09 13:18:50 ET, resumption trade 2026-11-09 13:23:50 ET.
- 2d agoMTRITrading halt: Mentari Therapeutics, Inc. Cmn (MTRI), Volatility trading pauseNasdaq Trading HaltsHalted 2026-11-09 13:12:45.266 ET, resumption quote 2026-11-09 13:12:45 ET, resumption trade 2026-11-09 13:17:45 ET.
- 2d agoMTRIMentari Therapeutics to Present at Upcoming Investor ConferencesGlobeNewswireWALTHAM, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Mentari Therapeutics, Inc. (NASDAQ:MTRI), a clinical-stage biotechnology company developing therapies for migraine prevention, today announced that members of
- 2d agoMTRIINMMentari Therapeutics to Present at Upcoming Investor ConferencesGlobeNewswireWALTHAM, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Mentari Therapeutics, Inc. (Nasdaq: MTRI), a clinical-stage biotechnology company developing therapies for migraine prevention, today announced that members of management will participate in the following upcoming investor conferences in November:
- 2d agoMTRIMentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million FinancingGlobeNewswireMentari is advancing a robust pipeline of biologics for the prevention of migraine, including MT-001 and MT-002, which target clinically validated pathways and have potential to address the two-thirds of people who have
- 6y agoMTRIGrocer Metro Gains, Loss of Sports Hits Rogers: Canada EarningsBloombergRevenue at grocery chain Metro Inc. jumped while Rogers Communications Inc. withdrew guidance as the coronavirus pandemic leaves its mark on Canadian first quarter earnings.
- 6y agoMTRIA Profit Implosion Is About to Test Canada’s Stock MarketBloombergThe Covid-19 health crisis quickly turned into an economic crisis that roiled stock markets worldwide. Now, a profit crisis is coming for Canadian stocks.
- 6y agoMTRIWinners Rise Amid the Losers in Canada’s $750 Billion Stock RoutBloombergThe confluence of the coronavirus outbreak and a global oil price war roiled Canada’s stocks this quarter, wiping out about $750 billion in value. But while the financial devastation was widespread, some corners of the market stayed afloat.
- 6y agoMTRILEHMQTwenty-Nine Days of Carnage: The Canadian Market Rout in ChartsBloombergIt has been a month like no other in financial markets.
- 9y agoTSLAEBAYAMZNGS+1Shopify Blows Away Revenue Estimates for Ninth Quarter in a RowBloombergCanadian e-commerce platform Shopify Inc. soared the most in almost a year and a half after beating analysts’ revenue estimates for a ninth quarter in a row, boosting the forecast for the current quarter and signing up a record number of new merchants.
- 9y agoMTRIAnother Canadian Utility Looks South of Border for M&A TargetsBloomberg